Background: It is still a matter of debate if and to what extent carotid endarterectomy (CEA) and carotid artery stenting (CAS) impair cognitive functioning in the elderly. Methods: We conducted a nonrandomized clinical trial on subjects with asymptomatic carotid artery stenosis comparing CEA (n = 28; 24 males and 4 females; 72.6 ± 5.8 years old) with CAS (n = 29; 17 males and 12 females; 75.1 ± 5.7 years old). Cognition, mood and functional status were evaluated by a broad spectrum of tests performed on the day prior to carotid reopening as well as 3 and 12 months after. Results: No significant differences in scores on cognitive tests including the Babcock story recall test and Rey’s auditory verbal learning test (memory), category naming test (verbal fluency), trail-making test parts A and B (attention and executive function) and controlled oral word association test (executive functioning) were observed 3 and 12 months after carotid reopening independent of the technique used. Only scores on the copy drawing test (visuospatial and constructional abilities) slightly but significantly (p < 0.05) worsened in the CAS group 12 months after the intervention. No significant differences between the CEA and CAS groups were detected regarding mood and functional status after 3 and 12 months. Conclusions: CEA and CAS seem to be safe procedures in elderly patients in terms of cognitive, mood and functional status in the short and long term. CAS might be preferred for the shorter hospital stay, but further studies with a larger number of old and oldest old subjects with a longer follow-up are needed to better understand the cost-effectiveness of both treatments.

Keywords:
Carotid endarterectomy, Carotid artery stenting, Cognition, Cognitive performance
1.
de Weerd M, Greving JP, de Jong AW, Buskens E, Bots ML: Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke 2009;40:1105–1113.
2.
Kakkos SK, Sabetai M, Tegos T, Stevens J, Thomas D, Griffin M, Geroulakos G, Nicolaides AN: Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg 2009;49:902–909.
3.
Bakker FC, Klijn CJ, Jennekens-Schinkel A, Kappelle LJ: Cognitive disorders in patients with occlusive disease of the carotid artery: a systematic review of the literature. J Neurol 2000;247:669–676.
4.
Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J: International trends in mortality from stroke, 1968 to 1994. Stroke 2000;31:1588–1601.
5.
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA: The lifetime risk of stroke: estimates from the Framingham study. Stroke 2006;37:345–350.
6.
Hachinski V: The 2005 Thomas Willis lecture: stroke and vascular cognitive impairment – a transdisciplinary, translational and transactional approach. Stroke 2007;38:1396.
7.
Desmond DW, Moroney JT, Sano M, Stern Y: Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002;33:2254–2260.
8.
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220–2241.
9.
Fisher M: Senile dementia: a new explanation of its causation. Can Med Assoc J 1951;65:1–7.
10.
Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T, Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH, Beneken JE, Gravenstein JS: Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857–861.
11.
Knipp SC, Matatko N, Wilhelm H, Schlamann M, Massoudy P, Forsting M, Diener HC, Jakob H: Evaluation of brain injury after coronary artery bypass grafting: a prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. Eur J Cardiothorac Surg 2004;25:791–800.
12.
Rasmussen LS: Postoperative cognitive dysfunction: incidence and prevention. Best Pract Res Clin Anaesthesiol 2006;20:315–330.
13.
Lal BK: Cognitive function after carotid artery revascularization. Vasc Endovascular Surg 2007;41:5–13.
14.
EVA-3S Investigators: Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial. Cerebrovasc Dis 2004;18:62–65.
15.
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–1501.
16.
Ringleb PA, Allenberg J, Brückmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W: 30-day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368:1239–1247.
17.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), ed 4, text rev. Washington, American Psychiatric Association, 2000.
18.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
19.
European Carotid Surgery Trialists Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379–1387.
20.
Cao P, de Rango P, Verzini F, Maselli A, Norgiolini L, Giordano G: Outcome of carotid stenting versus endarterectomy: a case-control study. Stroke 2006;37:1221–1226.
21.
Carlesimo GA, Caltagirone C, Gainotti G: The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996;36:378–384.
22.
Spinnler H, Tognoni G: Italian standardization and classification of neuropsychological tests. Italian Group for the Neuropsychological Study of Aging. Ital J Neurol Sci 1987;(suppl 8):1–120.
23.
Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Geront 1986;4:165–173.
24.
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged: the index of ADL – a standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.
25.
Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
26.
Mlekusch W, Mlekusch I, Haumer M, Kopp CW, Lehrner J, Ahmadi R, Koppensteiner R, Minar E, Schillinger M: Improvement of neurocognitive function after protected carotid artery stenting. Catheter Cardiovasc Interv 2008;71:114–119.
27.
Fratiglioni L, von Strauss ECQ: Epidemiology of the dementias in old age; in Jacoby R, Oppenheimer C, Dening TAT (eds): The Oxford Textbook of Old Age Psychiatry. Oxford, Oxford University Press, 2008, pp 391–406.
28.
de Rango P, Caso V, Leys D, Paciaroni M, Lenti M, Cao P: The role of carotid artery stenting and carotid endarterectomy in cognitive performance: a systematic review. Stroke 2008;39:3116–3127.
29.
Verzini F, Cao P, de Rango P, Parlani G, Maselli A, Romano L, Norgiolini L, Giordano G: Appropriateness of learning curve for carotid artery stenting: an analysis of periprocedural complications. J Vasc Surg 2006;44:1205–1211.
30.
Crawley F, Stygall J, Lunn S, Harrison M, Brown MM, Newman S: Comparison of microembolism detected by transcranial Doppler and neuropsychological sequelae of carotid surgery and percutaneous transluminal angioplasty. Stroke 2000;31:1329–1334.
31.
Sivaguru A, Gaines PA, Beard J, Venables GS: Neuropsychological outcome after carotid angioplasty: a randomised control trial. J Neurol Neurosurg Psychiatry 1999;66 (suppl):262.
32.
Schnaudigel S, Groschel K, Pilgram SM, Kastrup A: New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. Stroke 2008;39:1911–1919.
33.
Witt K, Borsch K, Daniels C, Walluscheck K, Alfke K, Jansen O, Czech N, Deuschl G, Stingele R: Neuropsychological consequences of endarterectomy and endovascular angioplasty with stent placement for treatment of symptomatic carotid stenosis: a prospective randomised study. J Neurol 2007;254:1524–1532.
34.
Korczyn AD, Vakhapova V: The prevention of the dementia epidemic. J Neurol Sci 2007;257:2–4.
35.
Lacroix V, Hammer F, Astarci P, Duprez T, Grandin C, Cosnard G, Peeters A, Verhelst R: Ischemic cerebral lesions after carotid surgery and carotid stenting. Eur J Vasc Endovasc Surg 2007;33:430–435.
36.
Ghorab K, Macian F, Adoukounou T, Magy L, Chapot R, Vallat JM: Carotid angioplasty stenting revisited: clinical and radiological (MRI) outcome. Cerebrovasc Dis 2008;25:21–25.
37.
Desmond DW: The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci 2004;226:3–7.
38.
Rothwell PM: Current status of carotid endarterectomy and stenting for symptomatic carotid stenosis. Cerebrovasc Dis 2007;24(suppl 1):116–125.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.